Skip to main content
. 2015 Oct 15;6(37):39924–39940. doi: 10.18632/oncotarget.5442

Table 1. Clinicopathologic characteristics of 12 patients with lung carcinoma.

Patient Gender Surgical procedure TNM Stage Histilogical type Tumor size (cm) Tumor extension Positive lymph nodes
1 M right pneumonectomy yT2N1 IIB adenocarcinoma 8 none intrapulmonary
2 M right upper lobectomy pT2N2 IIIA squamous cell carcinoma 3.5 none mediastinal
3 M right lower lobectomy pT2N0 IB squamous cell carcinoma 3.8 none none
4 M left upper lobectomy pT3 IIB squamous cell carcinoma 6 pleura none
5 M left pneumonectomy pT2N1 IIB squamous cell carcinoma 6 none intrapulmonary
6 M left upper lobectomy pT2N0 IB squamous cell carcinoma 4.5 none none
7 M left pneumonectomy pT1(LUL) pT2(LLL) N0 IA and IB squamous cell carcinoma (LUL) + adenocarcinoma (LLL) 1.5 (LUL) / 4 cm (LLL) visceral pleura none
8 M right upper lobectomy pT2N0 IB Epidermoid carcinoma 3.5 none none
9 F left pneumonectomy pT2N2 IIIA adenocarcinoma 9 visceral pleura mediastinal
10 M left pneumonectomy pT3N0 IIB squamous cell carcinoma 5 mediastinal pleura none
11 M right lower lobectomy pT2N0 IB adenocarcinoma 4.8 none none
12 F right upper lobectomy pT2N0 IB adenocarcinoma 7 none none

For each patient, numbered from 1 to 12, the relevant clinicopathologic characteristics, including their sex, surgical procedure, TNM classification, stage, histological type, size and extension of the primary tumors, and the presence of positive lymph nodes are shown. LUL (Left Upper Lobe) and LLL (Left Lower Lobe).